Delivery Order 36F79720D0189-36C24122F0150
Award Date
4/27/22
Potential Completion Date
10/31/22
Potential Value
$25K
Federal Agency
Veterans Integrated Service Network 1
Awardee
Incyte Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Chester Township, OH 45069, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order is for the drug PEMAZYRE and has a completion date of December 31, 2020. The contract was awarded on November 18, 2020 and utilizes Master Schedule contract FSS-61-IB, which provides pharmaceuticals and drugs to government agencies. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $12,725.23 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The firm fixed price order is for PEMAZYRE 9 MG tablets to fulfill requirements through September 30th, 2022. Place of performance will be Incyte Corporation's location in West Chester Township, Ohio. No set-aside designation was applied to this order to...
The Department of Veterans Affairs Veterans Health Administration awarded Incyte Corporation a $556.97 million firm fixed price delivery order against their Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide PEMAZYRE 9MG tablets to VHA facilities in Veterans Integrated Service Network 15. The place of performance is Incyte's location in Talleyville, Delaware and the period of performance runs from November 2020 through November 2021. No set aside designation or...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for a firm fixed price. The order is for PEMAZYRE 9 MG tablets to fulfill requirements under the referenced master agreement. Performance will take place in San Diego, California with completion by July 28, 2021. No set-aside provisions were applied to this...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Incyte Corporation. The firm fixed price order is for the provision of PEMIGATINIB (PEMAZYRE) 4.5MG tablets to the VA medical center located in Talleyville, Delaware, with performance taking place from July 28, 2023 through September 28, 2023. As the prime contractor, Incyte will...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 21 of the U.S. Department of Veterans Affairs (VA) to Incyte Corporation for the supply of the pharmaceutical drug Pemigatinib, marketed as Pemazyre. The $119,618.73 contract provides for the delivery of this anti-cancer medication to VA medical facilities across the country to support healthcare services for eligible veterans. Incyte, a global biopharmaceutical company, holds two major contract...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21 to Incyte Corporation, a global biopharmaceutical company. The $13,290.97 delivery order contract is for the drug Pemigatinib, which is used to treat certain types of cancer. The contract was awarded under Incyte's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, and has a firm fixed price. No set-aside...
This is a $19,994.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] to the Boro VAMC Pharmacy. The $6,048.81 contract, awarded in April 2024, has a completion date of May 2024. The order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and was not set aside for any socioeconomic category. Ardelyx currently holds two active...
The Department of Veterans Affairs Veterans Health Administration awarded a $678,720 delivery order to Emergent Devices Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is to replenish pharmaceutical inventory needs for the VA's Veterans Integrated Service Network 12 Central Ohio Medical Operations Support facility in Wayne, Pennsylvania, from August 3 to August 10, 2021. Emergent Devices will provide the requested refill of pharmacy items on a...